| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 430,000 | 13 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | 13 Jun 2023 | 1 | $0 | 4 | Chief Medical Officer | 15 Jun 2023, 18:19 |
| TCRX | TScan Therapeutics, Inc. | 02 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 06 Feb 2023, 16:14 |
| TCRX | TScan Therapeutics, Inc. | 05 Jul 2022 | 1 | $0 | 4 | Chief Medical Officer | 07 Jul 2022, 07:57 |
| TCRX | TScan Therapeutics, Inc. | 05 Jul 2022 | 0 | $0 | 3 | Chief Medical Officer | 07 Jul 2022, 07:54 |